Harrow Health, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HROW research report →
About the company
Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation.
- CEO
- Mark L. Baum
- IPO
- 2007
- Employees
- 382
- HQ
- Nashville, TN, US
Price Chart
- Market Cap
- $1.59B
- P/E
- -108.89
- P/S
- 5.93
- P/B
- 55.43
- EV/EBITDA
- 57.18
- Div Yield
- 0.00%
- Gross Margin
- 74.11%
- Op Margin
- 10.47%
- Net Margin
- -5.57%
- ROE
- -33.65%
- ROIC
- 8.55%
- Revenue
- $272.30M · 36.41%
- Net Income
- $-5,139,000 · 70.60%
- EPS
- $-0.14 · 71.43%
- Op Income
- $38.61M
- FCF YoY
- 170.24%
- 52W High
- $54.85
- 52W Low
- $28.54
- 50D MA
- $37.30
- 200D MA
- $41.34
- Beta
- 0.28
- Avg Volume
- 797.03K
Get TickerSpark's AI analysis on HROW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 18, 26 | Sternberg Perry J. | other | 5,248 |
| Jun 18, 26 | SILVERNAIL LAUREN P | other | 5,248 |
| Jun 18, 26 | Graves Adrienne L | other | 5,248 |
| May 18, 26 | Graves Adrienne L | buy | 1,000 |
| May 18, 26 | SILVERNAIL LAUREN P | buy | 1,000 |
| May 15, 26 | Shojaei Amir | other | 10,000 |
| May 14, 26 | BAUM MARK L | buy | 10,000 |
| May 14, 26 | BOLL ANDREW R. | buy | 3,500 |
| Mar 3, 26 | Opaleye Management Inc. | sell | 59,000 |
| Mar 4, 26 | Opaleye Management Inc. | sell | 134,000 |
Our HROW coverage
Recent articles, reports, and earnings notes.
No research on HROW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HROW report →Similar companies
Peers in the same neighborhood.